New Enroll for RBI, PFRDA & NABARD Intro Class! April 18 at 9:15 PM

    Question

    India Resurgence Fund (IRF), an investment platform

    promoted by Piramal Enterprises and Bain Capital, is going to acquire the active pharmaceutical ingredients (APIs) and contract research and manufacturing services (CRAMS) business of Ind-Swift Laboratories through its portfolio company Synthimed Labs?What is the acquisition amount given to the acquired company?
    A Rs.1550 crore Correct Answer Incorrect Answer
    B Rs.1650 crore Correct Answer Incorrect Answer
    C Rs.1780 crore Correct Answer Incorrect Answer
    D Rs.1920 crore Correct Answer Incorrect Answer
    E None of these Correct Answer Incorrect Answer

    Solution

    India Resurgence Fund (IRF), an investment platform promoted by Piramal Enterprises and Bain Capital, will acquire the active pharmaceutical ingredients (APIs) and contract research and manufacturing services (CRAMS) business of Ind-Swift Laboratories through its portfolio company Synthimed Labs for Rs 1,650 crore.

    Practice Next